Navigator Medicines, Inc., 2026-09-25
A new SEC Form D private-offering notice from San Mateo, CA, a $40,000,000 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Clinical-stage biotech developing bispecific antibodies targeting OX40L and TNFalpha for inflammatory and autoimmune diseases such as hidradenitis suppurativa.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- SpadEx inc., 2026-09-25, $3M, Santa Clara, CA
- Precision Neuroscience Corp, 2026-09-28, New York, NY
- BYTES RESTAURANT TECHNOLOGY, INC., 2026-09-25, $2.4M, Daly City, CA
- Way Biosolutions, Inc., 2026-09-25, $2M, Cambridge, MA
- Corerunway Inc, 2026-09-25, $650K, San Francisco, CA
- OptoVista Holdings, LLC, 2026-09-25, $3.7M, Washington, DC
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.